Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$9.15 USD
-0.13 (-1.40%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $9.13 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 21 - 40 ( 134 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Hitting the Gym with Apitegromab into the Clinic
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for SRRK 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Positive on Apitegromab?s Approval, and SRK-439?s Potential in Obesity; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
The Scholar Polishing the SAPPHIRE in Preparation for the Big Reveal
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
It?s a Great Time to be Experts in Myostatin Inhibition - Scholar Rock Looks to Target Obesity
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SAPPHIRE Topline Data in 2H24; SRK-181 Data in 2H23; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
KOLs Highlight Apitegromab?s Potential Through Detailed Patient Perspectives
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A